GÖRG, led by Frankfurt partner Markus Beyer, has advised the medical technology company KARL STORZ SE & Co. KG, based in Tuttlingen/Germany, on the takeover of the supplier medi G GmbH. The parties have agreed not to disclose the economics of the transaction.
KARL STORZ has already held a 25 per cent in medi-G since 2007. The acquisition of the outstanding 75 per cent was a strategic step to exploit synergies in terms of the product portfolio and supply chains. The transaction also offers both companies long-term security in terms of growth and production. With the takeover and integration of around 85 employees, the internationally active family business is securing both: additional expertise and new skills.
KARL STORZ was founded in 1945 and is now led by the third generation and is active in the fields of human and veterinary medicine. KARL STORZ employs 9,400 people worldwide, around 3,400 of whom working in the Tuttlingen area. With 13,000 products produced in Germany, USA, Switzerland and Estonia and sold worldwide, a turnover of over 2 billion euros ahs been achieved in 2023.
medi-G supplies KARL STORZ with various end products and complex assemblies. These products are primarily used in general and visceral surgery (laparoscopy), ear, nose and throat surgery and paediatrics
Advisors KARL STORZ SE & Co. KG
GÖRG Partnerschaft von Rechtsanwälten mbB
Markus Beyer (Lead, Partner, Corporate/M&A, Frankfurt am Main)
Florian Mayer (Associate, M&A/Corporate Law, Frankfurt am Main)
Dr Thomas Rieger (Partner, Restructuring, Stuttgart/Frankfurt am Main)
